Resources: Page 403

Elastography offers noninvasive assessment of liver fibrosis
By Kate Madden Yee
Monday, November 26 | 8:55 a.m.-9:05 a.m. | VSGI21-02 | Room N227Steatosis does not affect shear-wave elastography estimation of liver fibrosis -- but inflammation does, according to a presentation to be given on Monday by researchers from Massachusetts General Hospital.
November 6, 2012
CEUS comparable to MDCT for managing colorectal cancer patients
By Kate Madden Yee
Sunday, November 25 | 12:30 p.m.-1:00 p.m. | LL-GIS-SU2A | Lakeside Learning CenterContrast-enhanced ultrasound (CEUS) is comparable to MDCT in assessing patients undergoing antiangiogenic drug-based neoadjuvant therapy for colorectal cancer liver metastasis, according researchers from Italy.
November 6, 2012
US, MRI tumor measurements can predict residual disease
By Kate Madden Yee
Sunday, November 25 | 12:30 p.m.-1:00 p.m. | LL-BRS-SU5A | Lakeside Learning CenterHow best can doctors assess residual disease in inflammatory breast cancer patients who have undergone neoadjuvant chemotherapy? Find out in this Sunday poster presentation.
November 6, 2012
3D subharmonic imaging better than harmonics for in vivo perfusion estimates
By Kate Madden Yee
Sunday, November 25 | 11:25 a.m.-11:35 a.m. | SSA21-05 | Room S405AB3D contrast-enhanced subharmonic imaging works well to estimate perfusion in vivo, according to a presentation to be given on Sunday morning by researchers at Thomas Jefferson University in Philadelphia.
November 6, 2012
Annual breast US benefits women with dense tissue
By Kate Madden Yee
Sunday, November 25 | 11:25 a.m.-11:35 a.m. | SSA01-05 | Arie Crown TheaterSince the 2009 passage of the breast density notification law in Connecticut, radiologists have a legal obligation to inform patients with mammographically dense breast tissue that they may benefit from the addition of screening breast ultrasound. But how effective is that second round of screening?
November 6, 2012
Contrast-enhanced US tracks cancer response to drug therapy
By Kate Madden Yee
Sunday, November 25 | 11:15 a.m.-11:25 a.m. | SSA21-04 | Room S405ABVolumetric contrast-enhanced ultrasound can track positive early cancer response to systemic drug therapy, according to a presentation to be given by researchers from the University of Alabama on Sunday morning.
November 6, 2012
ABUS plus mammography finds cancer early in women with dense tissue
By Kate Madden Yee
Sunday, November 25 | 11:05 a.m.-11:15 a.m. | SSA01-03 | Arie Crown TheaterScreening with automated breast ultrasound (ABUS) -- as an adjunct to digital mammography -- detects early-stage, node-negative invasive carcinoma in asymptomatic women with dense breast tissue, according to researchers from George Washington University Medical Center. And finding these cancers could reduce breast cancer mortality rates.
November 6, 2012
Screening US valuable for women with dense breast tissue
By Kate Madden Yee
Sunday, November 25 | 10:55 a.m.-11:05 a.m. | SSA01-02 | Arie Crown TheaterScreening ultrasound is a valuable tool for women with dense breast tissue, as errors in mammographic interpretation can be high -- up to 28% according to recent data, researchers from South Korea will report in this scientific session.
November 6, 2012
US alone compares well to mammography for cancer detection
By Kate Madden Yee
Sunday, November 25 | 10:45 a.m.-10:55 a.m. | SSA01-01 | Arie Crown TheaterCould ultrasound serve as the primary screening test for breast cancer? In this Sunday morning presentation, researchers from the University of Pittsburgh will discuss results from a study that used American College of Radiology Imaging Network (ACRIN) 6666 data to evaluate outcomes of screening if ultrasound were the primary screening modality.
November 6, 2012
Road to RSNA 2012: Ultrasound Preview
By Kate Madden Yee
Could ultrasound be the primary screening test for breast cancer? Is the public served by the increasing use of handheld ultrasound? These questions and many more will be addressed at the upcoming RSNA meeting in Chicago
November 6, 2012
Road to RSNA 2012: Ultrasound Preview
3D Systems to show new Vidar digitizer at RSNA
By AuntMinnie.com staff writers
Printing technology firm 3D Systems has rolled out its Vidar Systems' DiagnosticPro Edge digitizer, which provides dual functionality for mammography and radiology on a single device.
November 5, 2012
Quantification replaces attenuation measurement for characterizing renal masses
By Eric Barnes
Friday, November 30 | 11:30 a.m.-11:40 a.m. | SST07-07 | Room E351Iodine quantification at dual-energy CT is a new diagnostic technique that can reduce the cost of additional tests in the characterization of renal masses, researchers from the University of Messina in Italy have found.
November 5, 2012
Previous Page
Page 403 of 726
Next Page